Colinz Laboratories Ltd Share Price

10.10

Open ()
Turnover (lac)
Prev. Close ()
Day's Vol.(shares)
Detailed Quote

Corporate Action

Period From
Period To
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 09-Oct-2019 - -
COLINZ LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/10/2019 ,inter alia, to consider and approve This is to inform the exchange that the meeting of the Board of Directors of the Company, pursuant to Regulation 29(2) of SEBI (LODR) Regulations, 2015, is scheduled to be held on 31st October, 2019 at 1.30 P.M. at the registered office of the Company at A-101, Pratik Industrial Estate, Next to Wockhardt Hospital, Mulund Goregaon Link Road ,Mumbai ,Maharashtra ,400078 inter-alia to consider, approve and take on record the Un-audited Financial Results of the Company for the quarter and half year ended 30th September,2019. Further the trading window for dealing in securities of the Company will be closed for the Promoters/Directors /Officers/Designated Employees including immediate relatives of the Company from with immediate effect till 48 hours after the conclusion of the Board meeting (both days inclusive). We would like to inform you that, the Board of Directors of the Company at their meeting held today i.e. 31st October, 2019 has, inter alia considered and approved Unaudited Financial Results (as per IND-AS ) for the quarter and half year ended on 30th September, 2019. Enclosed herewith a copy of the same along with a copy of Limited Review Report dated 31-10-2019 received from Vora & Associates, Chartered Accountants, Statutory Auditors of the Company with respect to Unaudited Financial Results for the quarter and half year ended on 30th September, 2019, along with Cash-Flow statement We would like to inform you that, the Board of Directors of the Company at their meeting held today i.e. 31st October, 2019 has, inter alia considered and approved Unaudited Financial Results (as per IND-AS ) for the quarter and half year ended on 30th September, 2019. Enclosed herewith a copy of the same along with a copy of Limited Review Report dated 31-10-2019 received from Vora & Associates, Chartered Accountants, Statutory Auditors of the Company with respect to Unaudited Financial Results for the quarter and half year ended on 30th September, 2019, along with Cash-Flow statement. (As Per BSE Announcement Dated 31.10.2019)
Board Meeting - 18-Jul-2019 - -
COLINZ LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2019 ,inter alia, to consider and approve This is to inform the exchange that the meeting of the Board of Directors of the Company, pursuant to Regulation 29(2) of SEBI (LODR) Regulations, 2015, is scheduled to be held on 31st July, 2019 at the registered office of the Company at A-101, Pratik Industrial Estate, Mulund-Goregaon Link Road , Bhandup West, Mumbai- 400078, inter-alia- 1. To consider, approve and take on record Un-audited Financial Results of the Company for the quarter ended 30th June, 2019. 2. To approve Directors Report for the year ended as on 31st March, 2019. 3. To approve draft notice of forthcoming Annual General Meeting. 1) Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations}, we hereby wish to inform you that the Board of Directors of the Company at their meeting held today, i.e. 31st July, 2019, inter-alia considered and approved the Un-Audited Financial Results of the Company for the quarter ended June 30, 2019. These Financial Results were subjected to Limited Review by the Statutory Auditors of the Company. Copy of the Un-Audited Financial Results pursuant to Regulation 33 of the Listing Regulations alongwith Limited Review Report of the Statutory Auditors thereon is enclosed herewith. 2) The Board also considered and approved Directors Report for the year ended 31st March, 2019 3) Further, the board also approved the draft notice of forthcoming 33rd Annual General Meeting of the Company. (As Per BSE Announcement Dated On 31/07/2019)
Board Meeting - 21-May-2019 - -
COLINZ LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2019 ,inter alia, to consider and approve This is to inform the exchange that the meeting of the Board of Directors of the Company, pursuant to Regulation 29(2) of SEBI (LODR) Regulations, 2015, is scheduled to be held on Thursday, 30th May, 2019 at the registered office of the Company Further the trading window closure for dealing in securities of the Company by the Promoters/Directors /Officers/Designated Employees including immediate relatives of the Company from 21st May, 2019 till 48 hours after announcement of financial results to the public i.e. till 1st June, 2019(both days inclusive). COLINZ LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2019 ,inter alia, to consider and approve This is to inform the exchange that the meeting of the Board of Directors of the Company, pursuant to Regulation 29(2) of SEBI (LODR) Regulations, 2015, is scheduled to be held on Thursday, 30th May, 2019 at the registered office of the Company Further the trading window closure for dealing in securities of the Company by the Promoters/Directors /Officers/Designated Employees including immediate relatives of the Company from 21st May, 2019 till 48 hours after announcement of financial results to the public i.e. till 1st June, 2019(both days inclusive). Outcome of Board Meeting held today i,e. 30th May, 2019 pursuant to Regulation 33 and Regulation 30 read with Part A of Schedule lll of SEBI (LODR) Regulations, 2015. (As Per BSE Announcement Dated 30.05.2019)
Board Meeting - 10-May-2019 - -
COLINZ LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2019 ,inter alia, to consider and approve The following points are to discussed in the meeting: 1. To take on record the resignation of Dr. Mani L. S. from the post of Managing Director of the Company. 2. To approve change in designation of Dr. Mani L.S. from the post of Managing Director to Non-Executive Director of the Company. 3. To consider the proposal to appoint Company Secretary & Compliance Officer of the Company. 4. To take on record the resignation of Mr. N .K. Menon, as a CFO of the Company. 5. To consider & approve the proposal for appointment of Chief Financial Officer (CFO) of the Company. Further the trading window for dealing in securities of the Company will be closed for the Promoters/Directors /Officers/Designated Employees including immediate relatives of the Company from 10th May, 2019 till 48 hours after the conclusion of the Board meeting i.e. till 22nd May, 2019 (both days inclusive). This is to inform that the Board of Directors of the Company has, at its meeting held on Monday, 20th May, 2019 at 1.30 p.m. (i.e. today) inter alia, considered and approved the attached appointments. The Meeting commenced at 1.30 P.M. and concluded at 5.00 P.M. This is for your information and record. Thanking you, Yours faithfully, OR COLINZ LABORATORIES LTD DR. MANI L.S. DIRECTOR DIN: 00825886 (As Per BSE Announcement Dated 20.05.2019)
Board Meeting - 07-Jan-2019 - -
COLINZ LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2019 ,inter alia, to consider and approve BSE Code: 531210 This is to inform the exchange that the meeting of the Board of Directors of the Company, pursuant to Regulation 29(2) of SEBI (LODR) Regulations, 2015, is scheduled to be held on Thursday, 31st January, 2019, at the registered office of the Company at A-101, Pratik Industrial Estate, Mulund Goregaon Link Road, Mumbai, Maharashtra, 400078, at 1.30 p.m. inter-alia to consider, approve and take on record the Un- audited Financial Results (IND-AS) of the Company for the quarter and nine months ended 31st December,2018. This is for your information and record. Thanking you, Yours faithfully, For COLINZ LABORATORIES LIMITED DIRECTOR DR. MANI L. S. DIN -00825886 We would like to inform you that, the Board of Directors of the Company at their meeting held today i.e. 31t /anuary, 2019 has, inter alia considered and approved Unaudited Financial Results 0ND-AS) for the quarter and nine months ended on 3l-st December,20lB. Enclosed herewith a copy of the same along with a copy of Limited Review-Report dated 3Lst fan, 20t9 received from Vora & Associates, Chartered Accountants, Statutory Auditors of the Company with respect to Unaudited Financial Results for the quarter and nine months ended on 31st December, 2078. The Meeting commenced at 1.30 PM and concluded at 2.30 p.m. This is for your information and record. Thanking you, Yours faithfully, Mr. N. K.MENON DIRECTOR DIN: 01111297 (As Per BSE Announcement Dated On 31/01/2019)